Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-07-04
2006-07-04
Ponnaluri, Padmashri (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S015000, C435S194000, C435S091500, C435S091500, C435S091500, C435S091500, C530S334000, C702S019000, C702S027000
Reexamination Certificate
active
07070936
ABSTRACT:
The present invention provides a method for identifying inhibitors of protein kinases. Methods are also provided for inhibiting protein kinase activity. Specific non-peptide protein tyrosine kinase inhibitor are provided. The protein kinases produced using the method of the present invention may be used to treat a number of conditions in patients, including cancer, psoriasis, arthrosclerosis, or immune system activity.
REFERENCES:
patent: 5464861 (1995-11-01), Dobrusin et al.
patent: 5532167 (1996-07-01), Cantley et al.
patent: 5552534 (1996-09-01), Hirschmann et al.
patent: 5648378 (1997-07-01), Huang
patent: 5705585 (1998-01-01), Hogan, Jr.
patent: 5736412 (1998-04-01), Zambias et al.
patent: 6011175 (2000-01-01), Sebti et al.
patent: 6420338 (2002-07-01), Schneider et al.
patent: 6552066 (2003-04-01), Sharpe et al.
Lawrence et al (1998) Pharmocol. Ther. 77(2):81-114.
Huang et al., “Polyhydroxylated 3-(N-Phenyl) Carbamoyl-2-Iminochromene Derivatives as Potent Inhibitors of Tyrosine Kinase p60C-STC,”Bioorganic&Medicinal Chemistry Letters5(20):2423-2428 (1995).
Casnellie et al.Adv. Enzyme Regul., 22:501-515 (1984).
Engström et al.Meth. Enzymol., 107:130-154 (1984).
Fukunaga et al.Protein Phosphorylation, Second Edition, Chapter 13, pp. 291-313 (1999).
Kemp et al.TIBS, 15:342-346 (1990).
Kemp et al.Meth. Enzymol., 200:121-134 (1991).
Marsilje et al.Bioorg. Med. Chem. Lett., 10:477-481 (2000).
Metfalf III et al.,Curr. Pharm. Design, 8:2049-2075 (2002).
Milkiewicz et al.Bioorg. Med. Chem. Lett., 10:483-486 (2000).
Pearson et al.Meth. Enzymol., 200:62-81 (1991).
Ruzzene et al.Protein Phosphorylation, Second Edition, Chapter 10, pp. 221-253 (1999).
SawyerExpert Opin. Investig. Drugs, 13(1):1-19 (2004).
ShoichetNature, 432:862-865 (2004).
Songyang et al.Meth. Mol. Biol., 87:87-98 (1998).
Sparks et al.Int. J. biochem., 18(6)497-504 (1986).
Tegge et al.Meth. Mil. Chem., 87:99-106.
Alfaro-Lopez et al.J. Med. Chem., 41:2252-2260 (1998).
Burke et al.J. Med. Chem., 36(4):425-432 (1993).
Choi “Development of a Cellular Mimetic Protein Kinase Assay and a Novel Methodology for Determining the Mode of Inhibition for Multisubstrate” thesis, Bell & Howell Co., Aug. (1999).
Faltynek et al.Biochem., 34:12404-12410 (1995).
Fry et al.Science, 265:1093-1095 (1994).
Hanke et al.J. Biol. Chem., 271(2):695-701 (1996).
Hsiao et al.Synthesis, pp. 1043-1046 (1998).
HubbardEMBO J., 16(18):5572-5581 (1997).
Kim et al.Int. J. Peptide Protein Res., 44:457-465 (1994).
Lai et al.J. Org. Chem., 61:1872-1874 (1996).
Lai et al.J. Peptide Res., 51:271-281 (1998).
Levitzki et al.Science,267:1782-1788 (1995).
Lou et al.Bioorg. Med. Chem., 4(5):677-682 (1996).
Mohammadi et al.cience, 276:955-960 (1997).
Nair et al.Synthesis, pp. 810-814 (1995).
Nair et al.J. Med. Chem., 38:4276-4283 (1995).
Patrick et al.DDT, 1(8):325-330 (1996).
Ramdas et al.Arch. Biochem. Biophys., 323(2):237-242 (1995).
Recastle et al.J. Med. Chem., 39:1823-1835 (1996).
Saperstein et al.Biochem., 28:5694-5701 (1989).
Sawutz et al.Biochem. Pharmacol., 51:1631-1638 (1996).
Showalter et al.Pharmacol. Ther., 76(1-3):55-71 (1997).
Thakkar et al.J. Med. Chem., 36:2950-2955 (1993).
Xu et al.Nature, 385:595-602 (1997).
Zheng et al.Biochem., 32:2154-2161 (1993).
Burke, et al.Acc. Chem. Res., 36:426-433 (2003).
Johnson, et al.,Nature Reviews, 1:696-709 (2002).
Levitzki,Acc. Chem. Res., 36:462-469 (2003).
Pestell, et al.Oncogene, 19:6607-6612 (2000).
McCluskey, et al.J. Med. Chem., 45:1151-1175 (2002).
Susa, et al.,TiPS, 21:489-495 (2000).
Zhang,Annu. Rev. Pharmacol. Toxicol., 42:209-234 (2002).
Hangauer, Jr. David G.
Marsilje Thomas H.
Milkiewicz Karen L.
Elrifi, Esq. Ivor R.
Erlacher, Esq. Heidi A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Ponnaluri Padmashri
The Research Foundation of State University of New York
LandOfFree
Method for designing protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for designing protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for designing protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3559593